Latest Class Actions News

Light & Wonder has been hit with a class action lawsuit in Victoria alleging misleading statements about its Dragon Train game, targeting shareholders who bought Chess Depositary Interests between May 2023 and September 2024. The company has pledged a vigorous defence amid ongoing legal challenges.

Australian Clinical Labs has been hit with a class action lawsuit linked to a 2022 cyberattack on Medlab Pathology, alleging breaches of consumer law and duty of care. The company denies the claims and plans a vigorous defence.

Shine Justice reshuffles its top management as Simon Morrison steps down from Managing Director to Executive Director to spearhead international growth, particularly in its burgeoning mass torts program, while Carolyn Barker AM maintains overall CEO leadership.

Collins Foods has formalised a settlement deed to resolve a long-running employee class action over 10-minute rest breaks, with Federal Court approval still pending.

Brambles has faced a mixed Federal Court ruling in a class action over its FY17 profit guidance, with some claims upheld and others dismissed. The financial impact remains uncertain as the company reviews the judgment and potential appeals.

EML Payments has received Supreme Court approval for its $37.36 million shareholder class action settlement, enabling the company to refocus on its strategic growth plans.

Collins Foods has agreed to settle a class action over employee 10-minute rest breaks for up to AUD 9 million, pending Federal Court approval. The settlement includes flexible terms based on participant numbers, with no admission of liability.

Shine Justice Ltd has reported a strong turnaround in its half-year results to December 2025, posting an 8% revenue increase and a return to profitability with a $6.7 million net profit. The legal services firm saw robust growth in personal injury litigation and ongoing class actions, despite cash flow challenges from delayed settlements.

Coles Group reported a 2.5% revenue increase to $23.7 billion for the half year ended January 2026, driven by strong supermarket sales, but earnings were weighed down by a $235 million provision linked to a Fair Work Ombudsman ruling. The company declared a fully franked interim dividend of 41 cents per share.

Lendlease Group reported a significant $318 million statutory loss for the half year ended December 2025, driven by impairments and lower transaction earnings. The company plans a $3 billion capital recycling program to reduce gearing and strengthen its balance sheet.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.